Cite
1105-P: The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme.
MLA
Crabtree, Thomas S. J., et al. “1105-P: The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme.” Diabetes, vol. 69, June 2020, p. N.PAG. EBSCOhost, https://doi.org/10.2337/db20-1105-P.
APA
Crabtree, T. S. J., Phillips, S. M., Evans, A., Sennik, D. K., Rohilla, A., Bickerton, A., Darzy, K. H., Winocour, P., Cull, M. L., Strzelecka, A., Raghavan, R. P., Gallen, I. W., Yadagiri, M., & Ryder, R. E. (2020). 1105-P: The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme. Diabetes, 69, N.PAG. https://doi.org/10.2337/db20-1105-P
Chicago
Crabtree, Thomas S.J., Suzanne M. Phillips, Alison Evans, Devesh K. Sennik, Anurita Rohilla, Alex Bickerton, Ken H. Darzy, et al. 2020. “1105-P: The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme.” Diabetes 69 (June): N.PAG. doi:10.2337/db20-1105-P.